Prescribing Trends of SGLT2i among Patients with T2DM at High Cardiorenal Risk

This annual webinar features renowned European endocrinologists. International experts will discuss current topics in diabetology. The webinar will be broadcast in English.

In this webinar we will review the place of sodium-glucose transport protein 2 (SGLT2) inhibitors in the current lists of recommendations for endocrinologists, nephrologists and cardiologists. Clinical cases of patients with chronic kidney disease and heart failure on the background of diabetes mellitus will be presented to your attention.